Has FDA Or Insurance Approved Stem Cells For Knee?

FDA and insurance have not approved stem cells for knee pain. As of this writing, stem cells have been approved by FDA and insurance pays for stem cells for cancer treatments. Stem cells are derived from bone marrow for the bone marrow transplants. The stem cells are natural and come from a donor. The stem cells used for knee pain are often from the umbilical cord of a healthy mother who gave birth to a healthy baby and the mother donate the cord blood which is rich in stem cells that are used to decrease inflammation and help your body regenerate cartilage, bone, muscle, tendons, and tissues.

Knee Pain limits mobility. Physical pain may lead to emotional distress and depression. Covering up the pain with opioids has led to an epidemic. Regenerative medicine may be the answer.


When will FDA and Insurance Approve Stem Cells For Pain?

And the time frame for the FDA to approve and for insurance to step up and pay for the treatments is really hard to tell.

Think about this.

It took insurance years and years to step up and pay for the stem cells that make bone marrow transplants successful. And this was a life and death situation, not a pain situation. So if you’re like a number of folks who think that they will wait until the FDA approves and insurance approves and starts to pay then you may be waiting a while.

Let’s get this clear. The FDA is a great organization and they definitely are working to protect all of us from dangerous situations when it comes to foods and drugs. The Food and Drug Administration oversees a tremendous amount of concerns and they do a beyond great job when you consider what they are tasked to handle.

But here’s a question that you have to ask yourself.

Do you think that your insurance company cares more about your welfare than you do? How about the FDA? Do you think they care for you more than you do? The answer is obviously now. And to be honest, do you blame them?

Here’s what we mean.

Nobody will care more for you than you and your loved ones. So making decisions based on what is best for you only if the FDA says it is best for you or only if insurance says they will pay for it does not necessarily mean that is the best path.

Now let’s be clear.

We believe the FDA has an extremely important and vital role to be played when it comes to safety. Withstanding this truth, the FDA has approved a number of drugs that have had some extremely devastating effects on a very large amount of people.

Did they do this on purpose? Of course not!

Just saying that they do the best they can and they just like no other government institution or privately-owned business is not perfect. So the raw truth is your health and well being really ultimately falls in your lap.

Yes, insurance may help offset costs and for a lot of people, regenerative cell therapy is out of their financial reach. We wish this was not the case. Yet, the medical future for so many people is made significantly brighter due to stem cell therapy and regenerative cell therapies. We get asked questions about insurance and the FDA in relation to stem cell therapy almost daily.

Here’s a recent dialogue a team member had to the question about why the FDA has not yet ‘approved’ all manners of stem cell therapy.

We hope it will help you to consider things from more than just the ‘big brother will take care of me’ perspective and give rise to conversations about how to strive to attain the quality of life that you deserve.

Will there still be questions? The answer is yes.

Even after the FDA approves even more stem cell therapies than they already have there will still be questions. We believe it is good to have questions. We believe it is good to get answers. We believe you are the best person to make decisions for your own health too because other entities are going to most likely either be distracted or could potentially have other motives.

Here’s a response to the question “Why hasn’t the FDA approved (all) stem cell therapy?” —

“Thanks for your question. The FDA is like most other government agencies… they don’t move quickly. They have provided guidelines. They also oversee the handling of umbilical cords in the use of regenerative cell therapy and their oversight provides the same rigorous standards applied to all organ donations. The future of medicine is going to heavily be weighted in cell therapy innovations. The FDA is doing its best to keep up with the pace of the innovations. Stem cell therapy and regenerative cell therapies are not a ‘cure-all’ and we advise that you be wary of any business saying things to this effect. We focus on chronic pain. We turn away a good amount of people of we believe the service will not provide them with levels of pain relief that’s worth the investment because insurance will not pay for this service yet. The FDA and insurance companies took a long time to ‘approve’ bone marrow transplants too. Yet, bone marrow transplants were still making a tremendously positive impact on many lives before the FDA or insurance ‘gave their blessing’. We’ve had people come to our seminar and ask about the FDA not approving this procedure yet, and a lady once said the FDA does not approve vitamins and people have been taking them for years and the FDA is not always right because they have a long history of recalls too. Some people even think that the big money that pharma companies have actually influenced what gets approved and what does not. ‘Mother Nature’ makes stem cells… not a pharma company so perhaps the pharma companies may not be too excited with the idea of something that could dramatically reduce the need for pain pills and many surgeries that represents billions to these companies? There’s a lot of layers to how things get approved. We believe the FDA is doing it’s best to get the right treatments to people in as timely a fashion as they can. In the meantime there are people like you can see below who is smiling with the results of regenerative cell therapy. Thanks again for your question. To learn more about stem cell therapy click here.”

Tiffany Campbell
Tiffany Campbell

Tiffany Campbell has over 12 years in clinical research. She has been the Executive Director at a leading institute and worked at Indiana University, Regenstrief & Indiana Clinical Translational Sciences Institute. She's been an international consultant with multiple clients including Google. Tiffany is a behavioral economics geek who loves her family including her pet Pomsky 'Luna' who has a special place in her heart. She has a passion & drives to create & grow products and businesses that change peoples' lives for the better.
More about Tiffany Campbell On Linkedin

Share on facebook
Share on google
Share on twitter
Share on linkedin
Share on pinterest